Consolidated PAT surges ~6.9x YoY to ₹33.7 Cr on 90% revenue growth; margin eases QoQ
PAT +593.3% YoY · revenue +89.7% · margins expanding
₹347.68 Cr
+89.7% YoY
₹33.68 Cr
+593.3% YoY
9.68%
+7pp YoY
₹27.93
Yasho Industries' consolidated PAT came in at ₹33.68 Cr for Q2 FY27, up ~5.9x YoY from ₹4.86 Cr, on consolidated revenue of ₹347.68 Cr, up 89.7% YoY from ₹183.30 Cr — a continuation of the volume-led ramp the company flagged on its Q1 call (42% volume growth, better capacity utilisation, favorable mix). No reliable street/consensus estimate for this specific quarter could be sourced, so the print is assessed against the company's own guidance rather than a street number. Standalone PAT grew even faster YoY (+968%, ₹2.87 Cr to ₹30.65 Cr) than consolidated (+593%) because the year-ago quarter's subsidiary contribution was proportionally larger than this quarter's — the headline consolidated number is the more complete read, but readers comparing to standalone should expect a steeper YoY jump there.
Q2 FY-2027 vs prior quarters
Sequentially, growth continued (revenue +13.0% QoQ versus Q1 FY27's ₹307.74 Cr) but profitability eased: PAT fell 6.6% QoQ from Q1's record ₹36.05 Cr, and OPM (EBITDA/revenue) slipped to 20.90% from 23.75% in Q1 (reported as 24.2% EBITDA margin on the Q1 call). NPM still expanded sharply YoY, from 2.65% to 9.69%, so the YoY margin story remains one of expansion — the QoQ dip reads as normalization off an unusually strong Q1 base rather than a deterioration, since this is a specialty-chemicals business with no obvious seasonal driver.
The stock went into the print at ₹3,343, down 21% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS (basic, consolidated) ₹27.93 for the quarter vs ₹4.03 a year ago and ₹29.90 last quarter.
No exceptional items in either the current or year-ago quarter — growth is entirely operational, not one-off driven.
FY28 revenue >₹1,600 Cr (raised from ₹1,500 Cr). Endeavor to maintain 24% EBITDA margin going forward. FY27 CAPEX ₹250 Cr (raised from ₹125 Cr) for two production buildings at Pakhajan. Targeting 30-40% annual revenue growth next few years backed by marquee customer long-term contracts.
— This quarter: met
On guidance: revenue growth of 90% YoY is far ahead of management's targeted 30-40% annual growth band, a clear beat on that front. Capex execution also tracks the raised FY27 target of ₹250 Cr for the two Pakhajan production buildings — ₹131.29 Cr was already deployed in H1 FY27 (capital work-in-progress rose from ₹10.04 Cr at FY26-end to ₹131.05 Cr), roughly half the full-year budget spent in the first half. The one guidance metric this quarter missed is margin: management's stated endeavor to maintain ~24% EBITDA margin wasn't met, with OPM at 20.90% versus Q1's 24.2%. No management press release was available for this result to cross-check commentary against the print, and the quarter's corporate-action record shows only the standard results-cycle events (trading window closure, board meeting notice) — no incremental deal or capacity announcements beyond the ongoing Pakhajan capex already reflected in the balance sheet.
W1
Whether OPM recovers toward management's ~24% EBITDA margin endeavor in Q3 FY27 after easing to 20.90% this quarter.
W2
Pace of the remaining Pakhajan capex (₹131 Cr of the ₹250 Cr FY27 budget already spent) and its effect on depreciation/finance costs as the two new buildings come online.
W3
Whether revenue growth holds near management's 30-40% annual growth target — H1 FY27 revenue of ₹655.42 Cr is already running well ahead of that band YoY.
No exceptional items in current or year-ago quarter; consolidated covers two wholly-owned subs (Yasho Industries Europe B.V., Yasho Inc), no NCI line; clean digital PDF, unambiguous column headers, both self-checks passed.
Informational and educational content only. Not investment advice.